Incretin-based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle: Editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis” - Tian-Yi Ren; Mohammed Eslam; Jian-Gao Fan (Clinical and Molecular Hepatology)